MediQuest Therapeutics, Inc. Release: Phase 3 Topical Drug for Raynaud's Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
12/14/2012 8:17:47 AM
More...
|
MediQuest Therapeutics, Inc. Takes Streamlined Route To VC Liquidity
8/21/2009 8:55:11 AM
More...
|
MediQuest Thera Raises $23M To Break Ground With Raynaud's Drug
5/29/2009 10:31:23 AM
More...
|